vs

Side-by-side financial comparison of Mobileye Global Inc. (MBLY) and MAXIMUS, INC. (MMS). Click either name above to swap in a different company.

Mobileye Global Inc. is the larger business by last-quarter revenue ($1.9B vs $1.3B, roughly 1.4× MAXIMUS, INC.). On growth, Mobileye Global Inc. posted the faster year-over-year revenue change (27.4% vs -4.1%). Over the past eight quarters, Mobileye Global Inc.'s revenue compounded faster (109.9% CAGR vs -0.1%).

Mobileye Global Inc. is a United States-domiciled, Israel-headquartered autonomous driving company. It is developing self-driving technologies and advanced driver-assistance systems (ADAS) including cameras, computer chips, and software. Mobileye was acquired by Intel in 2017 and went public again in 2022.

Maximus Inc. is an American government services company, with operations in countries including the United States, Canada, and the United Kingdom. Maximus provides administration and other services for Medicaid, Medicare, health care reform, welfare-to-work, and student loan servicing, among other government programs. The company is based in Tysons, Virginia, has 39,600 employees and a reported annual revenue of $5.3 billion in fiscal year 2024.

MBLY vs MMS — Head-to-Head

Bigger by revenue
MBLY
MBLY
1.4× larger
MBLY
$1.9B
$1.3B
MMS
Growing faster (revenue YoY)
MBLY
MBLY
+31.5% gap
MBLY
27.4%
-4.1%
MMS
Faster 2-yr revenue CAGR
MBLY
MBLY
Annualised
MBLY
109.9%
-0.1%
MMS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
MBLY
MBLY
MMS
MMS
Revenue
$1.9B
$1.3B
Net Profit
$93.9M
Gross Margin
14.2%
23.7%
Operating Margin
10.9%
Net Margin
7.0%
Revenue YoY
27.4%
-4.1%
Net Profit YoY
128.0%
EPS (diluted)
$1.70

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MBLY
MBLY
MMS
MMS
Q1 26
$1.9B
Q4 25
$446.0M
$1.3B
Q3 25
$504.0M
$1.3B
Q2 25
$506.0M
$1.3B
Q1 25
$438.0M
$1.4B
Q4 24
$490.0M
$1.4B
Q3 24
$486.0M
$1.3B
Q2 24
$439.0M
$1.3B
Net Profit
MBLY
MBLY
MMS
MMS
Q1 26
Q4 25
$-127.0M
$93.9M
Q3 25
$-96.0M
$75.3M
Q2 25
$-67.0M
$106.0M
Q1 25
$-102.0M
$96.6M
Q4 24
$-71.0M
$41.2M
Q3 24
$-2.7B
$72.5M
Q2 24
$-86.0M
$89.8M
Gross Margin
MBLY
MBLY
MMS
MMS
Q1 26
14.2%
Q4 25
45.3%
23.7%
Q3 25
48.2%
25.3%
Q2 25
49.8%
26.7%
Q1 25
47.3%
24.9%
Q4 24
49.2%
21.5%
Q3 24
48.8%
22.9%
Q2 24
47.6%
25.3%
Operating Margin
MBLY
MBLY
MMS
MMS
Q1 26
Q4 25
-31.4%
10.9%
Q3 25
-21.6%
9.3%
Q2 25
-14.6%
12.3%
Q1 25
-26.7%
11.2%
Q4 24
-17.6%
6.2%
Q3 24
-577.6%
8.5%
Q2 24
-21.4%
10.8%
Net Margin
MBLY
MBLY
MMS
MMS
Q1 26
Q4 25
-28.5%
7.0%
Q3 25
-19.0%
5.7%
Q2 25
-13.2%
7.9%
Q1 25
-23.3%
7.1%
Q4 24
-14.5%
2.9%
Q3 24
-558.6%
5.5%
Q2 24
-19.6%
6.8%
EPS (diluted)
MBLY
MBLY
MMS
MMS
Q1 26
Q4 25
$-0.15
$1.70
Q3 25
$-0.12
$1.27
Q2 25
$-0.08
$1.86
Q1 25
$-0.13
$1.69
Q4 24
$-0.09
$0.69
Q3 24
$-3.35
$1.18
Q2 24
$-0.11
$1.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MBLY
MBLY
MMS
MMS
Cash + ST InvestmentsLiquidity on hand
$1.2B
$137.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$8.2B
$1.7B
Total Assets
$8.7B
$4.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MBLY
MBLY
MMS
MMS
Q1 26
$1.2B
Q4 25
$1.8B
$137.6M
Q3 25
$1.7B
$222.4M
Q2 25
$1.7B
$59.8M
Q1 25
$1.5B
$108.1M
Q4 24
$1.4B
$72.7M
Q3 24
$1.3B
$183.1M
Q2 24
$1.2B
$102.8M
Stockholders' Equity
MBLY
MBLY
MMS
MMS
Q1 26
$8.2B
Q4 25
$11.9B
$1.7B
Q3 25
$11.9B
$1.7B
Q2 25
$12.1B
$1.8B
Q1 25
$12.0B
$1.7B
Q4 24
$12.1B
$1.6B
Q3 24
$12.1B
$1.8B
Q2 24
$14.7B
$1.8B
Total Assets
MBLY
MBLY
MMS
MMS
Q1 26
$8.7B
Q4 25
$12.5B
$4.2B
Q3 25
$12.5B
$4.1B
Q2 25
$12.6B
$4.5B
Q1 25
$12.5B
$4.2B
Q4 24
$12.6B
$4.1B
Q3 24
$12.6B
$4.1B
Q2 24
$15.3B
$4.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MBLY
MBLY
MMS
MMS
Operating Cash FlowLast quarter
$75.0M
$-244.4M
Free Cash FlowOCF − Capex
$-250.7M
FCF MarginFCF / Revenue
-18.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
-2.60×
TTM Free Cash FlowTrailing 4 quarters
$218.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MBLY
MBLY
MMS
MMS
Q1 26
$75.0M
Q4 25
$113.0M
$-244.4M
Q3 25
$167.0M
$649.4M
Q2 25
$213.0M
$-182.7M
Q1 25
$109.0M
$42.7M
Q4 24
$204.0M
$-80.0M
Q3 24
$126.0M
$163.8M
Q2 24
$30.0M
$199.3M
Free Cash Flow
MBLY
MBLY
MMS
MMS
Q1 26
Q4 25
$86.0M
$-250.7M
Q3 25
$143.0M
$641.8M
Q2 25
$199.0M
$-198.2M
Q1 25
$95.0M
$25.5M
Q4 24
$191.0M
$-103.0M
Q3 24
$104.0M
$131.9M
Q2 24
$6.0M
$164.6M
FCF Margin
MBLY
MBLY
MMS
MMS
Q1 26
Q4 25
19.3%
-18.6%
Q3 25
28.4%
48.7%
Q2 25
39.3%
-14.7%
Q1 25
21.7%
1.9%
Q4 24
39.0%
-7.3%
Q3 24
21.4%
10.0%
Q2 24
1.4%
12.5%
Capex Intensity
MBLY
MBLY
MMS
MMS
Q1 26
Q4 25
6.1%
0.5%
Q3 25
4.8%
0.6%
Q2 25
2.8%
1.1%
Q1 25
3.2%
1.3%
Q4 24
2.7%
1.6%
Q3 24
4.5%
2.4%
Q2 24
5.5%
2.6%
Cash Conversion
MBLY
MBLY
MMS
MMS
Q1 26
Q4 25
-2.60×
Q3 25
8.63×
Q2 25
-1.72×
Q1 25
0.44×
Q4 24
-1.94×
Q3 24
2.26×
Q2 24
2.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MBLY
MBLY

Segment breakdown not available.

MMS
MMS

Clinical Services$523.7M39%
Cost Plus Contracts$386.4M29%
Outside The United States$143.2M11%
International Government Agencies$141.0M10%
Technology Solutions$74.8M6%
Employment And Other$70.2M5%
Other Including Local Municipalities And Commercial Customers$17.6M1%

Related Comparisons